SEC Form 4 Filing Summary for Editas Medicine, Inc.

This filing details a transaction by O'Neill Gilmore Neil, CEO, Director, and 10% owner of Editas Medicine, Inc. On September 3, 2026, 5124 shares of Common Stock were disposed of at a weighted average price of $3.0372 per share. This sale was conducted under an automatic sales instruction plan to cover tax withholding obligations arising from the vesting of restricted stock units on September 2, 2026. The transaction was not a discretionary trade by the reporting person. The sale was executed through multiple trades at prices ranging from $3.0050 to $3.0372. Following this transaction, O'Neill Gilmore Neil holds 243,189 shares of Editas Medicine, Inc. common stock.